Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Azacitidine Combined With Venetoclax in Patients With Higher-risk Chronic Myelomonocytic Leukemia (AVENHIR)	Chronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Active, not recruiting	Phase 2	2026-09-29		NCT05768711

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
AbbVie	340
Groupe Francophone des Myelodysplasies	10

24 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Centre Henri Becquerel	Rouen	France	59
Centre Hospitalier Annecy Genevois - Site d'Annecy	Pringy	France	1
Centre Hospitalier de Mont de Marsan	Mont-de-Marsan	France	2
Centre Hospitalier Lyon Sud	Pierre-Bénite	France	51
CHRU de Limoges	Limoges	France	2
CHU d'Amiens	Amiens	France	12
CHU d'Angers	Angers	France	5
CHU de Bordeaux - Hôpital Haut-Lévêque	Pessac	France	3
CHU de Grenoble	Grenoble	France	22
CHU de Montpellier - Hôpital Saint Eloi	Montpellier	France	3
CHU de Poitiers	Poitiers	France	26
CHU de Tours - Hôpital Bretonneau	Tours	France	3
CHU Hôtel Dieu	Nantes	France	5
Hôpital Archet 1	Nice	France	2
Hôpital Avicenne	Bobigny	France	6
Hôpital Claude Huriez	Lille	France	6
Hôpital Cochin	Paris	France	56
Hôpital NOVO	Pontoise	France	6
Hôpital Pontchaillou	Rennes	France	6
Hôpital privé du Confluent SAS	Nantes	France	1
Hôpital privé Sévigné	Cesson-Sévigné	France	5
Hôpital Saint Louis	Paris	France	22
Institut Gustave Roussy	Villejuif	France	54
IUCT Oncopole	Toulouse	France	12

Clinical trials